Specialty Pharmacy

LEE011 plus letrozole may prove to be effective first-line breast cancer therapy.

Stool transplantation in patients who have an infection of the bowel with recurrent C. difficile shows promise.

HIV-infected patients may have worse outcomes in ocular syphilis than those without the virus.

Researchers unveil the molecular workings of MS drug Tecfidera using new technology.

Top news of the day from across the health care landscape.

Researchers discover which type of gut bacteria may influence the effectiveness of chemotherapy.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.

Top news of the week in oncology, and cancer drug development.

The loss of interleukin-33 allows tumors to hide from the immune system.

Top news of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The rise in indoor temperatures worsened respiratory symptom scores and increased the use of recuse inhalers, a new study found.

Researchers have uncovered the mechanisms of resistance to Yervoy in patients with skin cancer.

Continuous glucose monitoring system provides health care professionals with clear, visual snapshots of glucose levels.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.

Study quantifies global body composition changes in patients with hepatitis C.

Natural killer cells ‘trained’ to more effectively attack cancer cells in patients with AML.

Top news of the day from across the health care landscape.

With no current treatments for patients with aggressive MS, new study findings provide hope.

The combined use of radiation therapy and a neutrophil stimulant can increase anti-tumor immunity.

New insights into a gene with anti-cancer activity may grow options for cancer treatment.

Experimental hepatitis C medication treats genotypes 1 through 6.

Direct-acting antivirals may cause hepatitis B reactivation in patients with an HCV/HBV co-infection.

Study findings contribute to the development of personalized treatment approaches for young children with eczema.

A new report updates medical community on primary sclerosing cholangitis.

New study may have found a way to prevent the loss of physical strength in type 1 diabetes patients.

Top news of the day from across the health care landscape.

Enzyme found to promote immune suppression by blocking the activation of anti-tumor T cells.